Rothschild Investment LLC’s AstraZeneca AZN Stock Holding History

Rothschild Investment LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$126K	Sell	664 -28	-4%	-$5.27K	﹤0.01%	982
2026 Q1	$136K	Buy	692 +121	+21%	+$23.3K	0.01%	792
2025 Q4	$105K	Buy	571 +12	+2%	+$2.1K	0.01%	794
2025 Q3	$85.7K	Buy	559 +83	+17%	+$12.6K	﹤0.01%	837
2025 Q2	$66.5K	Buy	476 +3	+0.6%	+$420	﹤0.01%	724
2025 Q1	$69.5K	Sell	473 -126	-21%	-$18.2K	﹤0.01%	695
2024 Q4	$78.4K	Buy	599 +23	+4%	+$3.22K	0.01%	695
2024 Q3	$89.7K	Buy	576 +14	+2%	+$2.26K	0.01%	667
2024 Q2	$87.6K	Sell	562 -2,637	-82%	-$397K	0.01%	645
2024 Q1	$433K	Buy	3,199 +2,719	+566%	+$360K	0.03%	349
2023 Q4	$64.6K	Buy	+480	New	+$62.4K	0.01%	618

Other funds holding AZN

EPGL

Evelyn Partners Group Ltd London $46.9B AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Rothschild Investment LLC's AZN Position: Q2 2026 in Review

Rothschild Investment LLC reduced its AstraZeneca (AZN) stake by 4% in Q2 2026, selling an estimated $5.27K and leaving 664 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #982.

Rothschild Investment LLC first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. The position peaked at $433K in Q1 2024. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Rothschild Investment LLC held 664 shares of AstraZeneca worth $126K as of Q2 2026.
Rothschild Investment LLC sold 28 AstraZeneca shares in Q2 2026, an estimated $5.27K.
AstraZeneca made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #982 holding.
Rothschild Investment LLC first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
Rothschild Investment LLC's AstraZeneca position peaked at $433K in Q1 2024.
906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.